Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, S.
Right arrow Articles by Kurlan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, S.
Right arrow Articles by Kurlan, R.
NEUROLOGY 1993;43:1712
© 1993 American Academy of Neurology

The early course of the Tourette's syndrome clinical spectrum

Sylvia Park, BA, Peter G. Como, PhD, Lu Cui, MS and Roger Kurlan, MD

Departments of Neurology (S. Park and Drs. Como and Kurlan) and Biostatistics (L. Cui), University of Rochester School of Medicine, Rochester, NY.

We retrospectively studied 101 children with Tourette's syndrome to characterize the early course of illness and associated behavioral disturbances of attention deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), disruptive behavior (DB), and school problems (SP). For patients without ADHD (45%), OCD (50%), DB (67%), or SP (52%) at the time of initial evaluation, 13% developed ADHD, 8% OCD, 28% DB, and 25% SP during the observation period of 1.6 ± 1.3 years (range, 0.5 to 7 years). For patients with behavioral disturbances initially, the problems were controlled or resolved for many over time and with therapy: ADHD, 46%; OCD, 47%; DB, 50%; and SP, 67%. Medication changes, assessed after a drug adjustment period between the initial and first follow-up visits (6 ± 6 months), showed that drug dosages remained largely unchanged and few patients required the addition of new drugs: tic suppressants, 10%; anti-obsessional agents, 5%; and stimulants, 12%. Tic suppressants were withdrawn from 12%.

Address correspondence and reprint requests to Dr. Roger Kurlan, Department of Neurology, University of Rochester School of Medicine, 601 Elmwood Avenue, Rochester, NY 14642.

Supported by PHS grant #T35 HL07496 (Short-term Training, Students in Health Schools) to S.P.

Received July 31, 1992. Accepted for publication in final form January 11, 1993.




This article has been cited by other articles:


Home page
Clin Child Psychol PsychiatryHome page
A. Vogt and A. Carroll
The Variation and Variability of Tourette Syndrome: A Single Case Study Approach
Clinical Child Psychology and Psychiatry, April 1, 1999; 4(2): 247 - 264.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by AAN Enterprises, Inc.